Category: Uncategorized
-
Software Supply Chain Security: Why Platform is the Better Choice
Research Software Supply Chain Security: Why Platform is the Better Choice Securing your software supply chain shouldn’t feel like an endless maze of tools, vendors, and vulnerabilities. In our new eBook, Software Supply Chain Security: Why Platform is the Better Choice, we reveal how an integrated platform approach can give you the ultimate edge. Say…
-
The Ultimate Guide to JFrog Security
Research The Ultimate Guide to JFrog Security With threats evolving at every stage of the software development lifecycle, end-to-end visibility is essential. ‘The Ultimate Guide to JFrog Security’ shows how JFrog provides seamless DevOps and security management across the SDLC—all in one powerful, unified platform. Inside the whitepaper, you’ll discover How to manage vulnerabilities from…
-
Secure 3 Key Steps to Secure the Software Supply Chain
Research Secure 3 Key Steps to Secure the Software Supply Chain Securing your development process is crucial in today’s landscape of escalating software supply chain threats. Our eBook, “3 Key Steps to Secure Your Software Supply Chain,” provides your essential strategies. Why Download This eBook? Learn the best practices for managing and securing open-source software…
-
Securing the 7 Stages of the Software Supply Chain
Research Securing the 7 Stages of the Software Supply Chain Did you know a single vulnerability can compromise your entire software supply chain? In our new eBook, Securing the 7 Stages of the Software Supply Chain, we break down the essential tactics to protect every step of your development lifecycle—before threats have a chance to…
-
Gartner® Report: GenAI and CX: Act now or fall behind
Research Gartner® Report: GenAI and CX: Act now or fall behind Zoom’s research shows customer expectations are rising, yet companies are still figuring out Generative Al. The gap between expectations and reality is widening—act now before it’s too late. Generative Al offers huge opportunities, but anything mediocre risks hurting your brand. Gartner states: “GenAl is…
-
Using real-world data to optimize your next oncology protocol
Using real-world data to optimize your next oncology protocol Download the Playbook Oncology clinical trials are critical to advancing cancer treatment, yet they are often complex, costly, and prone to delays. To address these challenges, leveraging real-world data (RWD) at the protocol design stage offers significant opportunities for improvement. This playbook explores how high-quality RWD…
-
13 Day Decrease in Referral to Randomization Time
13 Day Decrease in Referral to Randomization Time A sponsor’s glaucoma and ocular hypertension studies were behind on enrollment. The sponsor had started an outreach campaign which was not providing the desired results. WCG developed a new recruitment strategy mid-study comprised of a multi-channel outreach campaign. Download Case Study
-
Case study: Genentech and Flatiron Health boost trial efficiency with pragmatic study design
Case study: Genentech and Flatiron Health boost trial efficiency with pragmatic study design Read the Case Study Flatiron Health partnered with Genentech and Foundation Medicine to create the Prospective Clinico-Genomic Study (PCG), supported by a platform designed to reduce the complexity and burden of clinical trials for both research teams and patients. This pragmatic study…
-
WCG Randomized 1,600 Participants for RSV Vaccine Trial
WCG Randomized 1,600 Participants for RSV Vaccine Trial A top 5 sponsor turned to WCG to recruit expecting mothers for its Phase III RSV vaccine trial. WCG support covered multiple countries and contributed almost one third of overall randomizations in the supported countries, bringing the study in ahead of schedule despite delays due to COVID-19…
-
Patient Engagement Throughout the Entire Product Lifecycle (October 2024)
Patient Engagement Throughout the Entire Product Lifecycle (October 2024) In the pharmaceutical industry, patient engagement should be centered in health education, communication, and strategy during drug discovery and throughout the product lifecycle. Cheryl Lubbert, CEO of Reverba, discusses the importance of a patient-first mindset in the industry. Download the Dedicated Dialogue What you will learn:…